We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
-5.3%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$791M
AUM Growth
-$139M
(-15%)
Cap. Flow
-$89.2M
Cap. Flow
% of AUM
-11.28%
Top 10 Holdings %
Top 10 Hldgs %
26.18%
Holding
586
New
64
Increased
133
Reduced
194
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$19.9M |
| 2 |
GameStop
GME
|
+$19.5M |
| 3 |
JNPR
Juniper Networks
JNPR
|
+$19.1M |
| 4 |
Eastman Chemical
EMN
|
+$19M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$18.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$25.8M |
| 2 |
Vulcan Materials
VMC
|
+$24.1M |
| 3 |
CVS Health
CVS
|
+$23.6M |
| 4 |
Tyson Foods
TSN
|
+$23.6M |
| 5 |
CMCSK
COMCAST CORP SPL A (NEW)
CMCSK
|
+$23.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 26.4% |
| 2 | Industrials | 14.28% |
| 3 | Consumer Staples | 5.75% |
| 4 | Technology | 5.6% |
| 5 | Materials | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
PUT
AstraZeneca
AZN
$263B
| $28.7K | ﹤0.01% |
50
-100
| -67% | -$6.58K |
|
|
TIF
302
DELISTED
Tiffany & Co.
TIF
| $28.6K | ﹤0.01% |
370
-44
| -11% | -$3.85K |
|
303
GSK
GSK
$103B
| $27.3K | ﹤0.01% |
+568
| New | +$29.6K |
|
304
D.R. Horton
DHI
$41B
| $26.9K | ﹤0.01% |
916
-601
| -40% | -$17.7K |
|
305
Lennar Class A
LEN
$20.4B
| $26.4K | ﹤0.01% |
576
-2
| -0.3% | -$98 |
|
|
JOY
306
DELISTED
Joy Global Inc
JOY
| $26.2K | ﹤0.01% |
1,754
+676
| +63% | +$16.4K |
|
307
Enovis
ENOV
$1.56B
| $23.5K | ﹤0.01% |
456
-15
| -3% | -$995 |
|
308
Wabtec
WAB
$51.1B
| $23.1K | ﹤0.01% |
262
-17
| -6% | -$1.62K |
|
309
Credicorp
BAP
$30.9B
| $21.5K | ﹤0.01% |
202
-29
| -13% | -$3.5K |
|
310
iShares MSCI France ETF
EWQ
$324M
| $21.4K | ﹤0.01% |
+888
| New | +$22.7K |
|
311
Hershey
HSY
$35.4B
| $20.9K | ﹤0.01% |
228
-3
| -1% | -$273 |
|
312
Trinity Industries
TRN
$2.97B
| $20.8K | ﹤0.01% |
1,274
-61
| -5% | -$1.16K |
|
313
Palo Alto Networks
PANW
$264B
| $20.5K | ﹤0.01% |
714
-3,342
| -82% | -$98.6K |
|
314
iShares Latin America 40 ETF
ILF
$3.77B
| $20.3K | ﹤0.01% |
897
-4,744
| -84% | -$122K |
|
315
MGM Resorts International
MGM
$11.7B
| $20.2K | ﹤0.01% |
1,097
-12,140
| -92% | -$243K |
|
316
Broadcom
AVGO
$1.82T
| $20K | ﹤0.01% |
1,600
-8,750
| -85% | -$111K |
|
317
Watsco Inc
WSO
$14.9B
| $19.8K | ﹤0.01% |
167
| – | – |
|
318
Marathon Petroleum
MPC
$90.3B
| $19.1K | ﹤0.01% |
412
+50
| +14% | +$2.57K |
|
319
3D Systems Corp
DDD
$420M
| $18.9K | ﹤0.01% |
1,633
-269
| -14% | -$3.73K |
|
320
Skyworks Solutions
SWKS
$9.06B
| $17.9K | ﹤0.01% |
213
-917
| -81% | -$83.9K |
|
321
RPM International
RPM
$13.7B
| $17.7K | ﹤0.01% |
422
-1
| -0.2% | -$46 |
|
322
Viatris
VTRS
$20.1B
| $17.1K | ﹤0.01% |
+426
| New | +$23.8K |
|
|
PXD
323
DELISTED
Pioneer Natural Resource Co.
PXD
| $15.8K | ﹤0.01% |
130
-884
| -87% | -$110K |
|
324
ProShares Ultra Bloomberg Crude Oil
UCO
$443M
| $15.8K | ﹤0.01% |
56
| – | – |
|
325
iShares MSCI Indonesia ETF
EIDO
$476M
| $15.5K | ﹤0.01% |
879
-216,921
| -100% | -$4.49M |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q3 2015 Portfolio in Review
As of Q3 2015, Exane Derivatives held 586 positions worth $791M, down 15% from $930M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Exane Derivatives withdrew a net $89.2M in Q3 2015, closing 58 positions and reducing 194 holdings. Its most notable exit was HCA Healthcare, an estimated $25.8M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, up from 13% a quarter earlier, followed by Industrials and Consumer Staples.
Against the trend, Exane Derivatives opened a new position in McKesson worth $17.4M.
- Exane Derivatives's largest Q3 2015 buy was McKesson: 94,079 shares worth $17.4M.
- Exane Derivatives added most to Eastman Chemical in Q3 2015, an estimated $19M increase.
- Exane Derivatives's biggest Q3 2015 reduction was Vulcan Materials, cutting an estimated $24.1M.
- Exane Derivatives fully exited HCA Healthcare in Q3 2015, selling an estimated $25.8M.
- Exane Derivatives's ten largest holdings make up 26% of its $791M portfolio in Q3 2015.
- Exane Derivatives opened 64 new positions and closed 58 in Q3 2015.
- Exane Derivatives's portfolio value fell 15% quarter-over-quarter to $791M.
Based on Exane Derivatives's 13F filing for Q3 2015, filed 13 Nov 2015.